PK
Highly rated in
14
conditions

Dr. Priya S. Kishnani

Lenox Baker Children's Hospital
Durham, NC
Highly rated in
14
conditions
Specialties:Pediatrics
Experience:36 Years
Clinical Trials:Currently Recruiting for 9 Trials
Accepts:New PatientsMedicare
Highly rated in
14
conditions
About|Expertise|Insurance|Location|Research
Areas of Expertise

Many doctors have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a doctor treats and their level of experience.

Check Dr. Priya S. Kishnani's experience treating your condition:
About Dr. Priya S. Kishnani

Priya Kishnani is a Pediatrics expert in Durham, North Carolina. Kishnani has been practicing medicine for over 36 years and is highly rated in 14 conditions, according to our data. Her top areas of expertise are Pompe Disease, Glycogen Storage Disease Type 3, Glycogen Storage Disease Type 9, and Hypophosphatasia (HPP). She is licensed to treat patients in North Carolina. Kishnani is currently accepting new patients.

Her clinical research consists of co-authoring 285 peer reviewed articles and participating in 19 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Priya S. Kishnani it is best to call her office and ask if your insurance is accepted.

Accepts Medicare

Dr. Priya S. Kishnani accepts the following insurance:

  •  Blue Cross Blue Shield
  •  Ambetter
  •  Bright Health
  •  Cigna
  •  Aetna
Call to see if your plan is accepted.
Locations
3000 Erwin Rd, Durham, NC 27705
Background & Education
Graduate Institution
Other, 1987
Specialties
Pediatrics
Licenses
Pediatrics in NC
Hospital Affiliations
Atrium Health Carolinas Medical Center
Duke University Hospital
Languages Spoken
English
Arabic
Gujarati
Hindi
Indian
Spanish
Gender
Female
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

18 Clinical Trials
GBE Deficiency (GSD IV and APBD) Natural History Study
Enrollment Status: Recruiting
Publish Date: November 17, 2022
Intervention Type: Other
Identification and Characterization of Novel Coding, Splicing and Non-Coding Variants That Contribute to Genetic Disorders
Enrollment Status: Recruiting
Publish Date: November 15, 2022
Cognitive and Neurological Pathologies in Pompe Disease
Enrollment Status: Recruiting
Publish Date: November 15, 2022
GSD VI and GSD IX Natural History
Enrollment Status: Recruiting
Publish Date: November 14, 2022
Intervention Type: Other
Determination of Cross-Reactive Immunological Material (CRIM) Status and Longitudinal Follow-up of Individuals With Pompe Disease
Enrollment Status: Recruiting
Publish Date: October 12, 2022
Intervention Type: Other
A Long-term Follow-up Study of Gaucher Disease
Enrollment Status: Recruiting
Publish Date: October 10, 2022
Immunophenotyping of Patients With MPS II Treated With Enzyme Replacement Therapy
Enrollment Status: Recruiting
Publish Date: June 06, 2022
Natural History Study of Adult and Pediatric Patients With Hypophosphatasia
Enrollment Status: Recruiting
Publish Date: January 31, 2022
The Down Syndrome Clinical Trials Network (DS-CTN) Study of Alzheimer's Disease in Down Syndrome
Enrollment Status: Recruiting
Publish Date: December 17, 2020
Developing a Management Approach for Patients With Late-Onset Pompe Disease GAA Variant Identified by Newborn Screening
Enrollment Status: Active, not recruiting
Publish Date: October 10, 2022
Intervention Type: Other
A Multicenter, Multinational, Observational Morquio A Registry Study (MARS)
Enrollment Status: Active, not recruiting
Publish Date: June 21, 2022
Intervention Type: Drug
An Open-Label, Fixed-Sequence, Ascending-Dose, First-in-Human Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Intravenous Infusions of ATB200 Co-Administered With Oral AT2221 in Adult Subjects With Pompe Disease
Enrollment Status: Active, not recruiting
Publish Date: June 13, 2022
Intervention Type: Drug
Study Drugs: ATB200AT2221
Study Phase: Phase 1/Phase 2
An Open-label, Multicenter, Single-arm, Phase 4 Study of the Effect of Treatment With Velaglucerase Alfa on Bone-related Pathology in Treatment-naïve Patients With Type 1 Gaucher Disease
Enrollment Status: Completed
Publish Date: February 01, 2022
Intervention Type: Dietary Supplement, Drug
Study Phase: Phase 4
Developmental Outcomes of School-aged Children With Infantile-onset Pompe Disease: A Telemedicine Approach to Assessment and Cognitive Training
Enrollment Status: Completed
Publish Date: October 28, 2021
A Multicenter, Randomized, Double-Blind, Parallel-Group Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) Enzyme Replacement Therapy Compared With Imiglucerase in Patients With Type I Gaucher Disease
Enrollment Status: Completed
Publish Date: June 08, 2021
Intervention Type: Biological
Study Phase: Phase 3
A Three-Month, Open-Label, Randomized, Dose-escalation Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of VAL-1221 Versus Myozyme®/Lumizyme® in Patients With Late-Onset GSD-II (Pompe Disease) Followed by Open-Label Treatment With VAL-1221 in All Patients
Enrollment Status: Terminated
Publish Date: June 02, 2020
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
A Phase 3 Switchover Study of the Efficacy and Safety of BMN 701 (GILT-tagged Recombinant Human GAA) and Long-Term Study for Extended Treatment in rhGAA Exposed Subjects With Late-onset Pompe Disease
Enrollment Status: Terminated
Publish Date: June 14, 2018
Intervention Type: Drug
Study Phase: Phase 3
A 20-Week Double-Blind Placebo Controlled Clinical Trial to Evaluate the Safety and Efficacy of Rivastigmine in Children (Ages 10-18) With Down Syndrome
Enrollment Status: Completed
Publish Date: April 06, 2015
Intervention Type: Drug, Other
Study Phase: Phase 1/Phase 2
View 9 Less Clinical Trials -
285 Total Publications
In Utero Enzyme-Replacement Therapy for Infantile-Onset Pompe's Disease.
Journal: The New England journal of medicine
Published: November 09, 2022
Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
HF
Dr. Henry S. Friedman
Pediatrics | Hematology Oncology | Neurosurgery
Highly rated in
16
conditions
Pediatrics
Hematology Oncology
Neurosurgery

Duke Health

The Preston Robert Tisch Brain Tumor Center

20 Duke Medicine Cir, 
Durham, NC 
 0.8 mi

Henry Friedman is a Pediatrics specialist and a Hematologist Oncology expert in Durham, North Carolina. Friedman has been practicing medicine for over 46 years and is highly rated in 16 conditions, according to our data. His top areas of expertise are Glioma, Astrocytoma, Glioblastoma, and Brain Tumor. He is licensed to treat patients in North Carolina. Friedman is currently accepting new patients.

JM
Dr. Joseph Muenzer
Pediatrics
Highly rated in
8
conditions
Pediatrics

UNC Health

UNC Health

101 Manning Dr, 
Chapel Hill, NC 
 8.9 mi

Joseph Muenzer is a Pediatrics expert in Chapel Hill, North Carolina. Muenzer has been practicing medicine for over 47 years and is highly rated in 8 conditions, according to our data. His top areas of expertise are Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), Mucopolysaccharidoses (MPS), Mucopolysaccharidosis Type 1 (MPS I, Hurler Syndrome), and Mucopolysaccharidosis Type 3A (MPS IIIA, Sanfilippo Syndrome A). He is licensed to treat patients in North Carolina. Muenzer is currently accepting new patients.

DK
Dr. Dwight D. Koeberl
Pediatrics
Highly rated in
6
conditions
Pediatrics

Duke Health

Duke University Hospital

2301 Erwin Rd, 
Durham, NC 
 0.7 mi

Dwight Koeberl is a Pediatrics expert in Durham, North Carolina. Koeberl has been practicing medicine for over 33 years and is highly rated in 6 conditions, according to our data. His top areas of expertise are Pompe Disease, Von Gierke Disease, Muscle Spasms, and X-Linked Creatine Deficiency. He is licensed to treat patients in North Carolina. Koeberl is currently accepting new patients.